InvestmentSep 24, 2026, 04:20 PM
Endovia Health Sciences Secures $510K Investment, Sells Shares Under ELOC
AI Summary
Endovia Health Sciences (formerly Splash Beverage Group) announced an initial investment of $510,000 from C/M Capital Master Fund, LP, via a secured convertible promissory note. This note, with a principal of $576,271, is convertible into common stock and matures in September 2027. The funds are earmarked for the regulatory advancement, clinical development, and commercialization of CannEpil®. Additionally, the company reported selling 3,629,250 shares of common stock for $808,829.42 under a previously disclosed equity line of credit facility with the same investor.
Key Highlights
- Endovia Health Sciences secured an initial investment of $510,000 from C/M Capital Master Fund, LP.
- The investment is in exchange for a secured convertible promissory note with a principal amount of $576,271.
- The note is convertible into common stock at a price of $1.75 per share or lower, based on market price.
- The company also sold 3,629,250 shares of common stock for $808,829.42 under an ELOC agreement.
- The investment supports regulatory advancement, clinical development, and commercialization of CannEpil®.
Price Impact
More from SBEV